Universitetssykehuset Nord-Norge HF

At Universitetssykehuset Nord-Norge HF in Tromsø, clinical research in neoplasms focuses on improving treatment options for several cancers, including endometrial cancer, non-small cell lung cancer, and esophageal squamous cell carcinoma. These studies are mainly designed to test new therapies and compare treatment strategies to help improve survival and disease control.

• Endometrial cancer: evaluating a new maintenance approach for advanced or recurrent disease
• Non-small cell lung cancer: assessing treatment effectiveness in patients with advanced KRAS G12C-mutated disease
• Esophageal squamous cell carcinoma: comparing two curative treatment strategies for operable locally advanced cancer
• Acute lymphoblastic leukemia: studying a protocol aimed at improving outcomes in infants with high-risk disease

Together, these trials reflect a strong focus on cancer research and blood disorders, with the goal of refining care for patients facing difficult-to-treat malignancies.

Research in immune system diseases at this site includes studies of atopic dermatitis and fetal and neonatal alloimmune thrombocytopenia. The work is aimed at evaluating new treatments that may better control symptoms, reduce risk, and improve outcomes for patients and at-risk pregnancies.

• Atopic dermatitis: testing a therapy for moderate to severe eczema in adolescents and adults
• Fetal and neonatal alloimmune thrombocytopenia: assessing a preventive treatment to lower the risk of severe disease in pregnancy

These trials highlight a mix of dermatology and maternal-fetal medicine, showing interest in both chronic inflammatory disease and pregnancy-related immune conditions.

The site also conducts studies in nutritional and metabolic diseases, especially non-alcoholic steatohepatitis, a liver condition linked to obesity, diabetes, and abnormal metabolism. This research is centered on testing potential therapies and understanding how to better manage liver inflammation and fibrosis.

• Non-alcoholic steatohepatitis: evaluating safety, tolerability, and biological effects of a new treatment approach
• Metabolism: exploring disease processes tied to liver fat accumulation and metabolic dysfunction

This area connects hepatology with broader metabolic research, reflecting efforts to address a growing chronic disease burden.

Clinical trials in nervous system diseases at Universitetssykehuset Nord-Norge HF include work on migraine. The main purpose is to evaluate whether existing or repurposed treatments can help prevent attacks and reduce the impact of this common neurological condition.

• Migraine: studying a preventive treatment to see if it can reduce the frequency or burden of episodes

This research supports ongoing efforts in neurology to improve symptom control and quality of life for people living with recurrent headaches.

The site’s respiratory tract diseases research includes studies in non-small cell lung cancer, with attention to treatment response in patients who may have additional health conditions. These trials are designed to assess how newer therapies can work in real-world patient groups and to support more personalized cancer care.

• Non-small cell lung cancer: evaluating a targeted treatment for advanced disease
• Biomarker-focused research: exploring whether patient characteristics can help guide treatment decisions

This area combines oncology and translational research, with an emphasis on making treatment choices more effective and better matched to individual patients.